INVESTOR RELATIONS

KEY FIGURES

Kedrion is a leading biopharmaceutical company that specializes in the development, production and distribution of plasma-derived therapeutic products for use in treating serious diseases, disorders and conditions such as immune system deficiencies and coagulation disorders.

With a commercial presence in 100 countries, we operate through a fully integrated business model from the collection of plasma in our own centers in the United States to fractionation and production in our manufacturing facilities located in Italy, Hungary and the United States.

PRESS RELEASES

Kedrion announces the closing of the first part of the transaction with Liminal

Kedrion signed the SPA on the Second Transaction with Liminal Bioscience

Kedrion and Kamada Announce FDA Approval of KEDRAB® Label Update

FINANCIAL REPORTS

KEDRION NOTES

CONTACT & EMAIL ALERTS

Subscribe to the service in order to receive our news


 

EN: Newsletter signup (Mailchimp)
Policy *
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

For more information please contact: [email protected]